(Q33931351)

30 July 2017

1 reference

title

Endovascular treatment of cerebral vasospasm (English)

1 reference

30 July 2017

Smith TP

1

1 reference

30 July 2017

Enterline DS

series ordinal

2

1 reference

30 July 2017

publication date

1 May 2000

1 reference

Journal of Vascular and Interventional Radiology

30 July 2017

published in

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

547-559

1 reference

Mechanisms of cerebral vasospasm in subarachnoid haemorrhage.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

A statistical analysis of factors related to symptomatic cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Subarachnoid haemorrhage: what happens to the cerebral arteries?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

A review of hemoglobin and the pathogenesis of cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

The pathophysiology of cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Arterial wall changes in early human vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Endovascular treatment of vasospasm.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Vasospasm diagnosis: theoretical and real transcranial Doppler sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Transluminal angioplasty for treatment of intracranial arterial vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Effect of balloon angioplasty on high grade symptomatic vasospasm after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Mechanism of action of balloon angioplasty in cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Angioplasty reduces pharmacologically mediated vasoconstriction in rabbit carotid arteries with and without vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Histological studies of intracranial vessels in primates following transluminal angioplasty for vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Percutaneous transluminal angioplasty in a canine model of cerebral vasospasm: angiographic, histologic, and pharmacologic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Long-term effects of in vivo angioplasty in normal and vasospastic canine carotid arteries: pharmacological and morphological analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Morphological changes in human cerebral arteries after percutaneous transluminal angioplasty for vasospasm caused by subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Cerebral vasospastic vessels: histologic changes after percutaneous transluminal angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Balloon angioplasty of the A1 segment of the anterior cerebral artery narrowed by vasospasm. Technical note.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Pre-operative micro-angioplasty of refractory vasospasm secondary to subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Balloon angioplasty for the treatment of vasospasm: results of first 50 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Severe symptomatic vasospasm: the role of immediate postoperative angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Fatal rupture of the intracranial carotid artery during transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Intravascular balloon dilatation therapy for intracranial arterial vasospasm: patient selection, technique, and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Morphological changes after percutaneous transluminal angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

In vivo angioplasty prevents the development of vasospasm in canine carotid arteries. Pharmacological and morphological analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Papaverine in cerebral angiospasm (vascular encephalopathy).

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Management of cerebral vasospasm in the 1990s.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Papaverine hydrochloride and experimental hemorrhagic cerebral arterial spasm

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Treatment of cerebral vasospasm with intra-arterial papaverine

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Intracranial pressure changes induced during papaverine infusion for treatment of vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Intra-arterial papaverine treatment for cerebral vasospasm: our experience and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Intra-arterial papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Technical considerations on intra-arterial papaverine hydrochloride for cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Incompatibility of Hexabrix and papaverine

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Effectiveness of intra-arterially infused papaverine solutions of various concentrations for the treatment of cerebral vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Repeat intra-arterial papaverine for recurrent cerebral vasospasm after subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Longitudinal time course of reversible and irreversible components of chronic cerebrovasospasm of the rabbit basilar artery.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Papaverine-sensitive vasospasm and arterial contractility and compliance after subarachnoid hemorrhage in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Paradoxical aggravation of vasospasm with papaverine infusion following aneurysmal subarachnoid hemorrhage. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Severe thrombocytopenia following intraarterial papaverine administration for treatment of vasospasm

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

The effects of papaverine on phorbol dibutyrate-induced vasoconstriction in brain slice microvessels

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Induced changes in intracranial pressure in the anesthetized rat and rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2807%2961605-4

7 January 2021

10.1016/S1051-0443(07)61605-4

Identifiers

DOI

1 reference

30 July 2017

1 reference